Batm Advanced Communicat... Share Discussion Threads

[wizzkid211] 15/1/2021 17:30

Our ambitious task: To be able to give in the region of 100% accurate diagnostics for any human or animal pathogen - bacterial, fungal or viral - within minutes.

www.batm.com/rns-rnr/posts/2021/january/diagnostics-and-viral-evolution/?fbclid=IwAR1whB2eDFH7xE9u65CkG5-tk2zZv-IYLocZ244Ab1K_h7kJabhZbFG2eOA

[doccash] 15/1/2021 15:57

Hot and continued interest in covid needs continual re-examination so more talk The telecom side I think is the more profitable arm in the medium term

[paulisi] 15/1/2021 13:00

You do get the impression that Zvi's focus is on the medical side and that the technology side will be sold off.

[unctuous] 14/1/2021 19:50

Zvi also mentions a diagnostic suite for “long covid”. That has significant potential over the next couple of years.

[paulisi] 14/1/2021 08:13

Nice start again - will it continue?

[paulisi] 13/1/2021 22:13

Fair play - sounds like they have a rapid test for sepsis and meningitis close to launch.Very little mention of NFV, which could be a game changer in the Telco side of the business

[paulisi] 13/1/2021 17:48

Back to a pound...

[paulisi] 13/1/2021 14:40

Price is on the move upwards..

[rawdeal1] 12/1/2021 17:06

We were expecting them to be mentioned in the New Year tips ..... did that happen (? IC).

[fse] 12/1/2021 15:26

I think the sale will go through as planned as there are penalty clauses if it does not so its fair to say its all but fait accomplis.
I thought they would use NGSoft services more in their own arena but honestly they appear subsidiary to their needs so they might as well let it go.
The price was a surprise as its a decent chunk of cash.

We did receive an update on the state of business with this comment

"BATM is focused on core areas of activity, underpinned by the Group's portfolio of intellectual property, that it expects will offer transformational growth opportunities in both its Networking & Cyber and Bio-Medical divisions. In particular, in 2020, the Group achieved fundamental milestones in progressing the development of its network function virtualisation ("NFV") activities, including a successful proof-of-concept of its NFVTime solution with Vodafone and securing its first tier 1 customer with a multi-year licensing agreement. In medical diagnostics, the Bio-Medical division rapidly produced multiple solutions in response to the COVID-19 outbreak that are experiencing substantial demand as the global pandemic continues."

>JD..... yes I do consider the company currently undervalued. Fair trading range IMO would be in the 120p range up to 160P. I topped up when the share price dipped below 100p. I rate them a BUY at these levels. Its good news for shareholders.

[wizzkid211] 12/1/2021 13:12

30m$ for legacy products from the days of NOKIA is a brilliant move and very good for all shareholders
let's hope the sale will go through

[paulisi] 12/1/2021 13:08

Increase the stake in Ador again?

[jimmywalkden] 12/1/2021 12:23

This deal looks to have raised around £30m which will be used to enhance the production capacity around core products, without resort to cash raising from investors.

This is another pointer to the increased confidence by management for the sales potential of these core products and looks like an excellent deal for shareholders.

[paulisi] 12/1/2021 09:43

I had a look a NG Soft's website and it does seem to be a run of the mill business based on web design and apps which IMHO has little growth potential.I can understand the logic.

[paulisi] 12/1/2021 09:10

Let's see if there is an interview on proactive investors and hopefully we may get a nugget or two of new information...

[wizzkid211] 12/1/2021 08:56

According to the company: "By 2020 the group has achieved key milestones in the development progress of its virtual network (NFV) operations, including successful completion of feasibility trials of its NFV solution with Vodafone and has secured a multi-year license agreement with First Tire-1 customer in the field. "Diagnostics, the BioMed division has rapidly developed a large number of solutions in response to the eruption of the corona, which are in great demand and increase as the epidemic continues."

"We treat viruses and other pathogens as a matter of routine, and as soon as we saw the corona virus spread we began to develop a series of diagnostic components needed to deal with the epidemic," describes Dr. Zvi Marom, co-founder and CEO of Batm. BATM has led to a 100% increase in its share price this year.

[james dean] 12/1/2021 08:15

After looking at the deal I feel excited that in the whole the group has much value and I think FSE would say the share price is under rated.

Great deal and opportunity for group to grow further.

[paulisi] 12/1/2021 07:26

Didn't see that coming - looks like a decent price. I wonder what the cash will be used for?

[wizzkid211] 12/1/2021 07:16

Disposal of legacy software services subsidiary to generate funds for acceleration of core activities
GOOD NEWS!

[fse] 09/1/2021 21:49

PCR test in the US for Covid19 currently runs about $200 a pop. Not cheap.

"Most COVID-19 diagnostic tests cost between $100 and $200. However, you may need to pay additional fees to cover the cost to administer the test, the office visit, and other tests. These fees will depend on your health insurance status, the test you receive, your site of care, and your symptom severity."

[wizzkid211] 09/1/2021 16:40

BATM now offers the 4 + 1 kit as its standard kit and is supplied to a number of private and government customers in Europe and other geographies.

[doccash] 09/1/2021 14:34

It would be nice to have UK business but the world is a big place and there will be plenty of interest

[paulisi] 08/1/2021 19:33

Unfortunately Zvi has no contracts with the UK government and has admitted as much.Whether the private airports take up a contract or not is down to Zvi's sales team.